FDA Inspection 1221559 - Baxter Healthcare Corporation - October 31, 2023

FDA Inspection 1221559 for Baxter Healthcare Corporation on October 31, 2023. Classification: Official Action Indicated (OAI).

View on Dashboard

One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.

Record Summary

FDA Inspection 1221559 for Baxter Healthcare Corporation on October 31, 2023. Classification: Official Action Indicated (OAI).

Violation Codes

21 CFR 211.100(a)

21 CFR 211.110(b)

21 CFR 211.160(a)

21 CFR 211.63

21 CFR 211.67(a)

Get More Insights

Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.

1.5M+ regulatory data points

Real-time compliance monitoring

Interactive analytics dashboard

Looking for more records? Our platform provides access to thousands of similar regulatory documents with advanced search and filtering capabilities.

Record Information

Company

Baxter Healthcare Corporation

Inspection Date

October 31, 2023

Product Type

Biologics

Office

Center for Biologics Evaluation and Research

ID: e56f6b7d-ffa0-4a4e-b741-2e06fe829dff

View on Dashboard

Transform Regulatory Data into Actionable Intelligence

Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.

Try KeyPedia Today

Explore our real use cases and discover our features in depth.

Subscribe to our newsletter

Get the latest updates and insights delivered to your inbox